Mesoblast Limited

MEOBF ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents $45.8M
Accounts Receivable $474.0K
Inventory —
Total Current Assets $63.6M
Property, Plant & Equipment —
Goodwill —
Intangible Assets (Excl. Goodwill) —
Total Assets $655.7M
Liabilities
Accounts Payable $21.8M
Total Current Liabilities $36.7M
Long-Term Debt —
Total Liabilities $138.9M
Stockholders' Equity
Retained Earnings $-344.9M
Total Stockholders' Equity $516.8M
← Newer Page 2 of 2 Older →